How many employees does Fulgent Genetics, Inc. have?

Fulgent Genetics, Inc. reported 1,300 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 27, 2026. That is up 30.0% from a year earlier.

What is Fulgent Genetics, Inc.'s revenue per employee?

Fulgent Genetics, Inc. brought in $323M of revenue in fiscal Dec 2025, which is $248K per employee. That ranks 19 of 26 companies we track in Medical - Diagnostics & Research, where the median is $366K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Fulgent Genetics, Inc. employees and revenue per employee

FLGT · Medical - Diagnostics & Research · $617M market cap

Fulgent Genetics, Inc. had 1,300 employees at the end of fiscal Dec 2025, up 30.0% from a year earlier. Revenue for the year was $323M, up 13.8% from a year earlier, or $248K per employee. Headcount grew faster than revenue.

Employees

1,300

+30.0% YoY

Revenue

$323M

+13.8% YoY

Revenue / employee

$248K

Peer median $366K

Rank in industry

19 of 26

Medical - Diagnostics & Research

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2016

Hover a year for the numbers.

FLGT employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	1,300	$323M	$248K	+30.0%	+13.8%
Dec 2024	1,000	$283M	$283K	-17.0%	-2.0%
Dec 2023	1,205	$289M	$240K	+19.1%	-53.3%
Dec 2022	1,012	$619M	$612K	+56.9%	-37.6%
Dec 2021	645	$993M	$1.54M	+50.3%	+135.4%
Dec 2020	429	$422M	$983K	+208.6%	+1196.5%
Dec 2019	139	$32.5M	$234K	+13.0%	+52.3%
Dec 2018	123	$21.4M	$174K	+25.5%	+14.0%
Dec 2017	98	$18.7M	$191K	+40.0%	+2.5%
Dec 2016	70	$18.3M	$261K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Fulgent Genetics, Inc. against similar companies

The closest industry peers by revenue, from Medical - Diagnostics & Research.

Company	Employees	Revenue	Revenue / employee	Shape
VCYT Veracyte, Inc.	755	$517M	$685K	Leaner
CDNA CareDx, Inc	761	$380M	$499K	Hiring ahead
BLLN BillionToOne, Inc.	713	$305M	$428K	—
GH Guardant Health, Inc.	2,490	$982M	$394K	Efficient growth
CSTL Castle Biosciences, Inc.	883	$344M	$390K	Hiring ahead
WGS GeneDx Holdings Corp.	1,300	$428M	$329K	Efficient growth
NEO NeoGenomics, Inc.	2,500	$727M	$291K	Hiring ahead
FLGT Fulgent Genetics, Inc.	1,300	$323M	$248K	Hiring ahead
GRAL GRAIL Inc.	910	$147M	$162K	Leaner

Every Healthcare company

Questions about Fulgent Genetics, Inc.

How many employees does Fulgent Genetics, Inc. have?: Fulgent Genetics, Inc. reported 1,300 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 27, 2026. That is up 30.0% from a year earlier.
What is Fulgent Genetics, Inc.'s revenue per employee?: Fulgent Genetics, Inc. brought in $323M of revenue in fiscal Dec 2025, which is $248K per employee. That ranks 19 of 26 companies we track in Medical - Diagnostics & Research, where the median is $366K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare FLGT with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Fulgent Genetics, Inc.'s annual reports (Form 10-K), latest filed February 27, 2026. This is data, not a recommendation to buy or sell FLGT.